The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products.


Updates from The Motley Fool

Latest updates on GlaxoSmithKline from Fool.com.  The Fool has written over 900 articles on GlaxoSmithKline.


Stock Performance

View Interactive GSK Charts
Sponsored by

Key Data Points

Primary metrics and data points about GlaxoSmithKline.
Current Price: $42.66
Prev Close: $42.77
Open: $42.79
Bid: $42.30
Ask: $43.00
Day's Range: $42.37 - $42.83
52wk Range: $37.20 - $45.58
Volume: 2,280,069
Avg Vol 2,331,731
Market Cap: $105B
P/E (ttm): 24.58
EPS (ttm): $0.00
Div & Yield: $1.95 (4.6%)

Company Rating

What our community thinks about GlaxoSmithKline.
CAPS Rating 3 out of 5
 
1408 Outperform
87 Underperform
CAPS All Stars
 
331 Outperform
26 Underperform

How do you think GlaxoSmithKline will perform against the market?



You pick for GlaxoSmithKline is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Emma Walmsley, CEO

93% Approve

Based on 50 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for GlaxoSmithKline.

The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products.

  • Exchange: NYSE
  • Sector: Healthcare
  • Industry: Drug Makers